BREAKING NEWS

Teva to start selling generic Viagra in US in 2017 after agreement with Pfizer

By GLOBES CORRESPONDENT

DECEMBER 18, 2013 11:10

Israeli pharmaceutical giant Teva has entered into an agreement with Pfizer Inc. to settle patent litigation related to Teva's generic version of Pfizer's Viagra tablets.

Under the terms of the agreement, Teva said that it will be able to launch its Abbreviated New Drug Application (ANDA) products pursuant to a royalty-bearing license on December 11, 2017, or earlier under certain circumstances. The terms of the settlement agreement are otherwise confidential.

The US Food and Drug Administration (FDA) has already granted tentative approval for Teva's generic version of Pfizer's 25, 50, and 100 mg. Viagra tablets.

Viagra had annual sales of $1.2 billion in the US, based on IMS sales data as of September 2013.

Iran and Russia can finalize nuclear plant agreements, Pezeshkian says

By REUTERS

01/17/2025 01:36 PM

WHO upbeat on scaling up aid under Gaza ceasefire terms

By REUTERS

01/17/2025 12:42 PM

Gov't set to meet at 3:30 p.m. to approve hostage deal

By AMICHAI STEIN

01/17/2025 12:02 PM

Netanyahu requests cancellation of testimony due to medical reasons

By JERUSALEM POST STAFF